{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:52:31Z","timestamp":1771609951159,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.virusres.2005.03.017","type":"journal-article","created":{"date-parts":[[2005,4,9]],"date-time":"2005-04-09T11:46:15Z","timestamp":1113047175000},"page":"101-105","source":"Crossref","is-referenced-by-count":67,"title":["Oral vaccination of dogs with recombinant rabies virus vaccines"],"prefix":"10.1016","volume":"111","author":[{"given":"Charles E.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen A.","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse","family":"Blanton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie","family":"Manangan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Morrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staci","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Niezgoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lillian A.","family":"Orciari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolin L.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Dietzschold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2005.03.017_bib1","series-title":"Lyssaviruses. Current Topics in Microbiology and Immunology","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-3-642-78490-3_13","article-title":"Oral rabies vaccination field trials in Europe, with recent emphasis on France","author":"Aubert","year":"1994"},{"key":"10.1016\/j.virusres.2005.03.017_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/vr.131.3.55","article-title":"Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus)","volume":"131","author":"Bingham","year":"1992","journal-title":"Vet. Rec."},{"key":"10.1016\/j.virusres.2005.03.017_bib3","first-page":"195","article-title":"Safety and efficacy of an antirabies vaccine consisting of recombinant vaccinia-rabies virus administered orally to the fox, dog and cat","volume":"20","author":"Blancou","year":"1989","journal-title":"Ann. Rech. Vet."},{"key":"10.1016\/j.virusres.2005.03.017_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/JVI.68.2.713-719.1994","article-title":"Rescue of synthetic genomic RNA analogs of rabies virus by plasmid-encoded proteins","volume":"68","author":"Conzelmann","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2005.03.017_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4269\/ajtmh.2003.69.155","article-title":"Evaluation of baits for delivery of oral rabies vaccine to dogs in Guatemala","volume":"69","author":"Corn","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virusres.2005.03.017_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virusres.2005.03.017_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2005.03.017_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/153685902317401735","article-title":"New approaches to the development of live attenuated rabies vaccines","volume":"21","author":"Dietzschold","year":"2002","journal-title":"Hybrid Hybridomics"},{"key":"10.1016\/j.virusres.2005.03.017_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1586\/14760584.2.3.399","article-title":"New approaches to the prevention and eradication of rabies","volume":"2","author":"Dietzschold","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virusres.2005.03.017_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-1-23","article-title":"Field trial with oral vaccination of dogs against rabies in the Philippines","volume":"1","author":"Estrada","year":"2001","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virusres.2005.03.017_bib11","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1128\/JVI.76.7.3374-3381.2002","article-title":"Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response","volume":"76","author":"Faber","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2005.03.017_bib12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0264-410X(95)00244-U","article-title":"Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs","volume":"14","author":"Fekadu","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.03.017_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0264-410X(94)90093-0","article-title":"Assay of oral vaccination of dogs against rabies in Tunisia with the vaccinal strain SADBern","volume":"12","author":"Haddad","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.03.017_bib14","first-page":"607","article-title":"Vaccination of Tunisian dogs with the lyophilised SAG2 oral rabies vaccine incorporated into the DBL2 dog bait","volume":"30","author":"Hammami","year":"1999","journal-title":"Vet. Res."},{"key":"10.1016\/j.virusres.2005.03.017_bib15","series-title":"Laboratory Techniques in Rabies","first-page":"80","article-title":"The mouse inoculation test","author":"Koprowski","year":"1996"},{"key":"10.1016\/j.virusres.2005.03.017_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.7589\/0090-3558-37.1.119","article-title":"Elimination of rabies from red foxes in eastern Ontario","volume":"37","author":"MacInnes","year":"2001","journal-title":"J. Wildl. Dis."},{"key":"10.1016\/j.virusres.2005.03.017_bib17","series-title":"Lyssaviruses. Current Topics in Microbiology and Immunology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-78490-3_1","article-title":"Rationale and prospects for rabies elimination in developing countries","author":"Meslin","year":"1994"},{"key":"10.1016\/j.virusres.2005.03.017_bib18","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1016\/S0264-410X(01)00064-0","article-title":"Genetic engineering of live rabies vaccines","volume":"19","author":"Morimoto","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.03.017_bib19","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/S0264-410X(01)00186-4","article-title":"Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination","volume":"19","author":"Orciari","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2005.03.017_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4038\/cmj.v45i2.8002","article-title":"Feasibility of canine oral rabies vaccination in Sri Lanka\u2013a preliminary report","volume":"45","author":"Perera","year":"2000","journal-title":"Ceylon Med. J."},{"key":"10.1016\/j.virusres.2005.03.017_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/infdis\/161.1.27","article-title":"A recombinant human adenovirus vaccine against rabies","volume":"161","author":"Preve","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2005.03.017_bib22","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1128\/JVI.75.22.10800-10807.2001","article-title":"Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity","volume":"75","author":"Pulmanausahakul","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2005.03.017_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0928-0197(97)10003-4","article-title":"Molecular epidemiology of rabies epizootics in Texas","volume":"8","author":"Rohde","year":"1997","journal-title":"Clin. Diagn. Virol."},{"key":"10.1016\/j.virusres.2005.03.017_bib24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.7589\/0090-3558-28.4.629","article-title":"Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores","volume":"28","author":"Rupprecht","year":"1992","journal-title":"J. Wildl. Dis."},{"key":"10.1016\/j.virusres.2005.03.017_bib25","first-page":"228","article-title":"Oral rabies vaccination of dogs","volume":"34","author":"Rupprecht","year":"1998","journal-title":"Isr. J. Vet. Med."},{"key":"10.1016\/j.virusres.2005.03.017_bib26","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1056\/NEJMoa010560","article-title":"Human infection due to recombinant vaccinia-rabies glycoprotein virus","volume":"345","author":"Rupprecht","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2005.03.017_bib27","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1002\/j.1460-2075.1994.tb06739.x","article-title":"Infectious rabies viruses from cloned cDNA","volume":"13","author":"Schnell","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.virusres.2005.03.017_bib28","first-page":"459","article-title":"SAG2 oral rabies vaccine","volume":"60","author":"Schumacher","year":"1993","journal-title":"Onderspoort J. Vet. Res."},{"key":"10.1016\/j.virusres.2005.03.017_bib29","doi-asserted-by":"crossref","unstructured":"Slate, D., Chipman, R.B., Rupprecht, C.E., DeLiberto, T., 2002. Oral rabies vaccination: a national perspective on program development and implementation. In: Timm R.M., Schmidt, R.H. (Eds.), Proceedings of the 20th Vertebrate Pest Conference. Davis, University of California Press, pp. 232\u2013240.","DOI":"10.5070\/V420110213"},{"key":"10.1016\/j.virusres.2005.03.017_bib30","series-title":"Laboratory Techniques in Rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.virusres.2005.03.017_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/vr.139.2.32","article-title":"Progress and setbacks in the oral immunisation of foxes against rabies in Europe","volume":"139","author":"Stohr","year":"1996","journal-title":"Vet. Rec."},{"key":"10.1016\/j.virusres.2005.03.017_bib32","first-page":"53","article-title":"Quantification of residual virulence of the Vnukovo-32\/107 rabies virus vaccination strain","volume":"40","author":"Svrcek","year":"1995","journal-title":"Vet. Med. (Praha)."},{"key":"10.1016\/j.virusres.2005.03.017_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/S0950268899002666","article-title":"An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species","volume":"123","author":"Vos","year":"1999","journal-title":"Epidem. Infect."},{"key":"10.1016\/j.virusres.2005.03.017_bib34","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1099\/0022-1317-82-9-2191","article-title":"Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration","volume":"82","author":"Vos","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2005.03.017_bib35","series-title":"Rabies","first-page":"365","article-title":"Control of wildlife rabies: Europe","author":"Wandeler","year":"1988"},{"key":"10.1016\/j.virusres.2005.03.017_bib36","series-title":"The Natural History of Rabies","first-page":"485","article-title":"Oral immunization of wildlife","author":"Wandeler","year":"1991"},{"key":"10.1016\/j.virusres.2005.03.017_bib37","first-page":"455","article-title":"Oral immunization against rabies: afterthoughts and foresight","volume":"142","author":"Wandeler","year":"2000","journal-title":"Schweiz. Arch. Tierheilkd."},{"key":"10.1016\/j.virusres.2005.03.017_bib38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/oxfordjournals.aje.a112302","article-title":"Oral rabies vaccine: evaluation of its infectivity in three species of rodents","volume":"104","author":"Winkler","year":"1976","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virusres.2005.03.017_bib39","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1073\/pnas.81.22.7194","article-title":"Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene","volume":"81","author":"Wiktor","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virusres.2005.03.017_bib40","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","article-title":"Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier","volume":"77","author":"Xiang","year":"2003","journal-title":"J. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020500081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016817020500081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T18:52:38Z","timestamp":1586199158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016817020500081X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S016817020500081X"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2005.03.017","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}